Accelerate Diagnostics Announces Pricing Of ~$15M Public Offering And Private Placement; The Public Offering Price For Each Unit Is $1.50 And The Public Offering Price For Each Pre-Funded Unit Is $1.49
Portfolio Pulse from Benzinga Newsdesk
Accelerate Diagnostics, Inc. (AXDX) has priced an underwritten public offering of approximately $15 million, consisting of units at $1.50 each and pre-funded units at $1.49 each. The offering includes common stock and warrants, with an additional option for underwriters to purchase more shares and/or warrants. The warrants are exercisable at $1.65 per share and the pre-funded warrants at $0.01 per share. The public offering is expected to close on January 23, 2024. Concurrently, a private placement to the Jack W. Schuler Living Trust will sell units at $1.73 per unit, with expected gross proceeds of $4.7 million. William Blair & Company, L.L.C. is the sole book-running manager, and Craig-Hallum Capital Group LLC is the co-manager.
January 19, 2024 | 2:21 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Accelerate Diagnostics has announced a public offering and private placement which may dilute current shareholders but also provides capital for the company's operations and growth.
The announcement of a public offering and private placement typically leads to short-term negative pressure on a company's stock price due to the potential dilution of existing shares. However, the capital raised can be beneficial for the company's long-term growth.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100